Mostrando 8 resultados de: 8
Filtros aplicados
Publisher
Experimental and Clinical Psychopharmacology(2)
Ageing Research Reviews(1)
Bioanalysis(1)
Drug Metabolism and Drug Interactions(1)
Drug Metabolism and Personalized Therapy(1)
Área temáticas
Enfermedades(2)
Bioquímica(1)
Fisiología humana(1)
Ginecología, obstetricia, pediatría, geriatría(1)
Medicina y salud(1)
Origen
scopus(8)
Clinical drug-drug interactions: Focus on venlafaxine
ReviewAbstract: Venlafaxine (VEN) is an antidepressant agent widely used nowadays as an alternative to selective serPalabras claves:Drug-drug interactions, pharmacodynamics, pharmacokinetics, VenlafaxineAutores:Adrián LLerena, Alves G., Falcao A.C., Magalhães P.Fuentes:scopusFirst MEPS/HPLC assay for the simultaneous determination of venlafaxine and O-desmethylvenlafaxine in human plasma
ArticleAbstract: Background: A new high-performance liquid chromatography-fluorescence detection assay based on microPalabras claves:Autores:Adrián LLerena, Alves G., Falcao A.C., Magalhães P., Rodrigues M.Fuentes:scopusPharmacogenetics and therapeutic drug monitoring of fluoxetine in a real-world setting: A PK/PD analysis of the influence of (Non-)genetic factors
ArticleAbstract: This work presents the GnG-PK/PD-AD study-a pharmacokinetics/pharmacodynamics (PK/PD) analysis of thPalabras claves:Biomarkers, Fluoxetine, pharmacogenetics, Real-world data, Therapeutic drug monitoringAutores:Adrián LLerena, Alves G., Falcao A.C., Fortuna A., Magalhães P.Fuentes:scopusVenlafaxine pharmacokinetics focused on drug metabolism and potential biomarkers
ReviewAbstract: Venlafaxine (VEN) is one of the safest and most effective drugs used in the treatment of selective sPalabras claves:Biomarkers, metabolism, pharmacokinetics, Therapeutic drug monitoring (TDM), Venlafaxine (VEN)Autores:Adrián LLerena, Alves G., Falcao A.C., Magalhães P.Fuentes:scopusReal-World Clinical Characterization of Subjects With Depression Treated With Antidepressant Drugs Focused on (Non-)Genetic Factors, Pharmacokinetics, and Clinical Outcomes: GnG-PK/PD-AD Study
ArticleAbstract: This work aimed to describe and characterize the GnG-PK/PD-AD study and the population of subjects dPalabras claves:antidepressants, Cytochrome p450, P-Glycoprotein, pharmacogenetics, Real-world settingAutores:Adrián LLerena, Alves G., Falcao A.C., Fortuna A., Magalhães P.Fuentes:scopusPopulation pharmacokinetics of digoxin in pediatric patients
ArticleAbstract: Digoxin pharmacokinetics were studied in a pediatric population with an age range of 6 days to 1 yeaPalabras claves:Digoxin, pediatric patients, Population pharmacokineticsAutores:Arranz I., Falcao A.C., Francisco J.López Hernández, González M.C., Lanao J.M., Martín-Suárez A., Outeda M., Quero M.Fuentes:scopusTargeting brain Renin-Angiotensin System for the prevention and treatment of Alzheimer's disease: Past, present and future
ReviewAbstract: Alzheimer's disease (AD) is a well-known neurodegenerative disease characterized by the presence ofPalabras claves:Alzheimer's disease, Angiotensin, Angiotensin converting enzyme, Angiotensin II receptor blockers, Renin-angiotensin systemAutores:Antoni Camins, Bicker J., Cruz M.T., Ettcheto M., Falcao A.C., Fortuna A., Gouveia F.Fuentes:scopusTherapeutic drug monitoring of fluoxetine, norfluoxetine and paroxetine: A new tool based on microextraction by packed sorbent coupled to liquid chromatography
ArticleAbstract: The present article reports the first liquid chromatography (LC) assay for the simultaneous quantifiPalabras claves:Autores:Adrián LLerena, Alves G., Falcao A.C., Magalhães P.Fuentes:scopus